Next Article in Journal
Precision Medicine Revolutionizing Esophageal Cancer Treatment: Surmounting Hurdles and Enhancing Therapeutic Efficacy through Targeted Drug Therapies
Previous Article in Journal
A Comprehensive Review on the Role of Human Epidermal Growth Factor Receptor 2 (HER2) as a Biomarker in Extra-Mammary and Extra-Gastric Cancers
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

Onco: A Promising Player Amidst Oncology Journals

by
Constantin N. Baxevanis
1,2
1
Cancer Immunology and Immunotherapy Center, Saint Savas Cancer Hospital, 11522 Athens, Greece
2
Cancer Research Center, Saint Savas Cancer Hospital, 11522 Athens, Greece
Onco 2023, 3(2), 125-126; https://doi.org/10.3390/onco3020009
Submission received: 24 May 2023 / Accepted: 1 June 2023 / Published: 1 June 2023

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

As the new Editor-in-Chief of the journal, I believe that I must continue the efforts of my predecessor even more actively and with greater enthusiasm and dedication so that the journal becomes a pole of attraction for the publication of excellent studies of basic, translational and clinical research for the treatment of cancer [...]

Share and Cite

MDPI and ACS Style

Baxevanis, C.N. Onco: A Promising Player Amidst Oncology Journals. Onco 2023, 3, 125-126. https://doi.org/10.3390/onco3020009

AMA Style

Baxevanis CN. Onco: A Promising Player Amidst Oncology Journals. Onco. 2023; 3(2):125-126. https://doi.org/10.3390/onco3020009

Chicago/Turabian Style

Baxevanis, Constantin N. 2023. "Onco: A Promising Player Amidst Oncology Journals" Onco 3, no. 2: 125-126. https://doi.org/10.3390/onco3020009

APA Style

Baxevanis, C. N. (2023). Onco: A Promising Player Amidst Oncology Journals. Onco, 3(2), 125-126. https://doi.org/10.3390/onco3020009

Article Metrics

Back to TopTop